dostarlimab
gsk
['rectal']
single agent pd-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer. talk by dr #asco22 #rectalcancer 
Pt Adv, NCI Rectal Anal TF
Mom, lifelong learner
Wants to bring patient voice to research, clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology